Bruno Colombo

Bruno Colombo

Auto-generated profile, based on publicly available information

Bruno Colombo

Vita-Salute University

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in The Lancet Neurology
Verified
Journal Article
Closed access
MRMaria A Rocca
Maria A Rocca
BCBruno Colombo
Bruno Colombo
AFAndrea Falini
Andrea Falini
AGAngelo Ghezzi
Angelo Ghezzi
VMVittorio Martinelli
Vittorio Martinelli
Massimo FilippiMassimo Filippi
Massimo Filippi

30 August 2019 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
TGThe Italian chronic migraine group
The Italian chronic migraine group
EAElio Clemente Agostoni
Elio Clemente Agostoni
Piero BarbantiPiero Barbanti
Piero Barbanti
PCPaolo Calabresi
Paolo Calabresi
BCBruno Colombo
Bruno Colombo
ARAntonio Russo
Antonio Russo
Chronic migraine is a disabling condition that is currently underdiagnosed and undertreated. In this narrative review, we discuss the future of chronic migraine management in relation to recent progress in evidence-based pharmacological treatment. Patients with chronic migraine require prophylactic therapy to reduce the frequency of migraine attacks, but the only currently available evidence-based prophylactic treatment options for chronic migraine are topiramate and onabotulinumtoxinA. Improved prophylactic therapy is needed to reduce the high burden of chronic migraine in Italy. Monoclonal antibodies that target the calcitonin gene-related peptide (CGRP) pathway of migraine pathogenesis have been specifically developed for the prophylactic treatment of chronic migraine. These anti-CGRP/R monoclonal antibodies have demonstrated good efficacy and excellent tolerability in phase II and III clinical trials, and offer new hope to patients who are currently not taking any prophylactic therapy or not benefitting from their current treatment. Treatment of chronic migraine is a dynamic and rapidly advancing area of research. New developments in this field have the potential to improve the diagnosis and provide more individualised treatments for this condition. Establishing a culture of prevention is essential for reducing the personal, social and economic burden of chronic migraine.

26 July 2000 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
BCBruno Colombo
Bruno Colombo
FBfilippo martinelli boneschi
filippo martinelli boneschi
PRPaolo Rossi
Paolo Rossi
MRMarco Rovaris
Marco Rovaris
LMLuca Maderna
Luca Maderna
GCGiancarlo Comi
Giancarlo Comi

1 May 2006 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
BCB. Colombo
B. Colombo
PAP. O. L. Annovazzi
P. O. L. Annovazzi
GCG. Comi
G. Comi

28 May 2014 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
BCBruno Colombo
Bruno Colombo
LSLorenzo Saraceno
Lorenzo Saraceno
GCGiancarlo Comi
Giancarlo Comi

27 May 2015 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
BCBruno Colombo
Bruno Colombo
MRMaria Assunta Rocca
Maria Assunta Rocca
RMRoberta Messina
Roberta Messina
SGSimone Guerrieri
Simone Guerrieri
Massimo FilippiMassimo Filippi
Massimo Filippi